Trial Profile

A phase 2a study of sublingual psilocybin for the potential treatment of Major Depressive Disorder

Status: Not yet recruiting

Phase of Trial: Phase II

Latest Information Update: 25 May 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

18 May 2021 Status changed from planning to not yet recruiting, according to a Cybin media release.
18 May 2021 According to a Cybin media release, the Institutional Review Board ("IRB") at the University of the West Indies Hospital, in Jamaica has granted approval to commence the study and commencement of the clinical trial is subject to final confirmation of study material specifications by Jamaica's Ministry of Health.
23 Nov 2020 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com